EMIS meets expectations

LEEDS-based EMIS Group, the UK’s biggest supplier of healthcare software to GPs, has revealed that its trading performance met expectations last year.

In a trading statement, EMIS said recurring revenue continued at more than 80 per cent in 2011.

In the second half of the year, a further 207 GP practices “went live” with EMIS Web, the statement said.

Hide Ad
Hide Ad

At the year end there were 360 GP live practices and 147 extended primary care organisations using EMIS Web, 1,565 orders for EMIS Web and 2,359 practices in the EMIS Web Familiarisation Service.

The group said it was continuing to prepare for the accelerated roll-out of EMIS Web and, during the second half of 2011, the number of employees rose from 876 to 950.

The group also acquired an additional freehold property in north Leeds, at a cost of approximately £2m in December 2011, providing the extra capacity to continue the group’s growth and support its investment plans.

The group’s UK market penetration remains strong with 53.1 per cent of GP practices using its services.

Hide Ad
Hide Ad

RX Systems, the group’s pharmacy system provider, is continuing to grow its market share.

The group said it continued to maintain a strong balance sheet with net cash of £7.8m at December 31 2011, compared with net cash of £1.7m at the end of 2010.

Sean Riddell, the EMIS Group chief executive, said: “EMIS group continues to trade in line with management expectations, enabling healthcare professionals to use and share patient data in a secure, time efficient and cost-effective manner.

“Through EMIS Web, the group is making significant progress towards delivery of the strategic vision of cross-organisational healthcare systems: a vision that remains completely aligned with NHS strategy for the future.

Hide Ad
Hide Ad

“RX Systems is increasing its market share and EMIS IQ and patient.co.uk are already addressing the growing demand for secure clinical information from the NHS and patients alike.

“The outlook for the new financial year is positive and we remain confident of the group’s strategic positioning and growth prospects.”

Related topics: